Clinical Trial Update: Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating the efficacy and safety of CM9241GRU in patients with perennial allergic rhinitis. The study is currently not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis

Drugs mentioned

• CM9241GRU

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: NOT_YET_RECRUITING